|
| Decoding poxvirus genome |
|
https://doi.org/10.18632/oncotarget.5892
Zhilong Yang, and Bernard Moss
|
| 28513-28514 |
|
| A 4D view on mRNA |
|
https://doi.org/10.18632/oncotarget.5121
Carlas Smith, Li-Chun Tu, and David Grunwald
|
| 28515-28516 |
|
| Snitrosylation and MSCmediated body composition |
|
https://doi.org/10.18632/oncotarget.5672
Yenong Cao, Wayne Balkan, and Joshua M. Hare
|
| 28517-28518 |
|
| Type I collagen fibrils: an inducer of invadosomes |
|
https://doi.org/10.18632/oncotarget.5804
Julie Di Martino, Violaine Moreau, and Frederic Saltel
|
| 28519-28520 |
|
| Neuroimmune signaling by extracellular vesicles |
|
https://doi.org/10.18632/oncotarget.5249
Stefan Momma
|
| 28521-28522 |
|
| Enhancing immunity by engineering DAMPs |
|
https://doi.org/10.18632/oncotarget.5251
Felice Cervone, Frederick M. Ausubel, and Giulia De Lorenzo
|
| 28523-28524 |
|
| STAT2directed pathogen responses |
|
https://doi.org/10.18632/oncotarget.5266
Hans Bluyssen
|
| 28525-28526 |
|
| Crosspresentation of antigens by dendritic cells: role of autophagy |
|
https://doi.org/10.18632/oncotarget.5268
Mrinmoy Das, Srini V. Kaveri, and Jagadeesh Bayry
|
| 28527-28528 |
|
| Protective CD8+ T cell memory without help |
|
https://doi.org/10.18632/oncotarget.5449
Min Fang, and Luis J. Sigal
|
| 28529-28530 |
|
| MCPIP: a key player in macrophage polarization |
|
https://doi.org/10.18632/oncotarget.5451
Pappachan Kolattukudy
|
| 28531-28532 |
|
| Defensins versus pathogens: an unfolding story |
|
https://doi.org/10.18632/oncotarget.5109
Elena Kudryashova, Wuyuan Lu, and Dmitri S. Kudryashov
|
| 28533-28534 |
|
| Quelling an innate response to dsRNA |
|
https://doi.org/10.18632/oncotarget.5110
Kristen M. Ogden, and B. V. Venkataram Prasad
|
| 28535-28536 |
|
| DNAM1: would the real natural killer cell please stand up |
|
https://doi.org/10.18632/oncotarget.5952
Nicholas D. Huntington, Ludovic Martinet, and Mark J. Smyth
|
| 28537-28538 |
|
| A novel human truncated IL12rβ1Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation |
|
https://doi.org/10.18632/oncotarget.5164
Wei Guo, Chen Wang, Xin Wang, Cheng Luo, Dongmei Yu, Yuheng Wang, Yucong Chen, Wen Lei, Xiangdong Gao, and Wenbing Yao
|
| 28539-28555 |
|
| MicroRNA146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis |
|
https://doi.org/10.18632/oncotarget.5597
Marah C. Runtsch, Ruozhen Hu, Margaret Alexander, Jared Wallace, Dominique Kagele, Charisse Petersen, John F. Valentine, Noah C. Welker, Mary P. Bronner, Xinjian Chen, Daniel P. Smith, Nadim J. Ajami, Joseph F. Petrosino, June L. Round, and Ryan M. O’Connell
|
| 28556-28572 |
|
| Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties |
|
https://doi.org/10.18632/oncotarget.5611
Kshitij Gupta, Akhil Kotian, Hariharan Subramanian, Henry Daniell, and Hydar Ali
|
| 28573-28587 |
|
| CD8+ T cells undergo activation and programmed death1 repression in the liver of aged Ae2ab–/– mice favoring autoimmune cholangitis |
|
https://doi.org/10.18632/oncotarget.5665
Axel R. Concepcion, January T. Salas, Elena Sáez, Sarai Sarvide, Alex Ferrer, Ainhoa Portu, Iker Uriarte, Sandra Hervás-Stubbs, Ronald P.J. Oude Elferink, Jesús Prieto, and Juan F. Medina
|
| 28588-28606 |
|
| Nickel chloride NiCl2caused inflammatory responses via activation of NFκB pathway and reduction of antiinflammatory mediator expression in the kidney |
|
https://doi.org/10.18632/oncotarget.5759
Hongrui Guo, Huidan Deng, Hengmin Cui, Xi Peng, Jing Fang, Zhicai Zuo, Junliang Deng, Xun Wang, Bangyuan Wu, and Kejie Chen
|
| 28607-28620 |
|
| PDGF upregulates CLEC2 to induce T regulatory cells |
|
https://doi.org/10.18632/oncotarget.5765
Sudhanshu Agrawal, Sreerupa Ganguly, Pega Hajian, Jia-Ning Cao, and Anshu Agrawal
|
| 28621-28632 |
|
| Antigenspecific human NKT cells from tuberculosis patients produce IL21 to help B cells for the production of immunoglobulins |
|
https://doi.org/10.18632/oncotarget.5764
Changyou Wu, Zitao Li, Xiaoying Fu, Sifei Yu, Suihua Lao, and Binyan Yang
|
| 28633-28645 |
|
| A genome wide transcriptional model of the complex response to preTCR signalling during thymocyte differentiation |
|
https://doi.org/10.18632/oncotarget.5796
Hemant Sahni, Susan Ross, Alessandro Barbarulo, Anisha Solanki, Ching-In Lau, Anna Furmanski, José Ignacio Saldaña, Masahiro Ono, Mike Hubank, Martino Barenco, and Tessa Crompton
|
| 28646-28660 |
|
| Vanadium toxicity in the thymic development |
|
https://doi.org/10.18632/oncotarget.5798
Wei Cui, Hongrui Guo, and Hengmin Cui
|
| 28661-28677 |
|
| Caffeine affects the biological responses of human hematopoietic cells of myeloid lineage via downregulation of the mTOR pathway and xanthine oxidase activity |
|
https://doi.org/10.18632/oncotarget.5212
Bernhard F. Gibbs, Isabel Gonçalves Silva, Alexandr Prokhorov, Maryam Abooali, Inna Yasinska, Maxwell A. Casely-Hayford, Steffen M. Berger, Elizaveta Fasler-Kan, and Vadim Sumbayev
|
| 28678-28692 |
|
| Molecular and clinical profiles of syndecan1 in solid and hematological cancer for prognosis and precision medicine |
|
https://doi.org/10.18632/oncotarget.4981
Mohamed R. Akl, Poonam Nagpal, Nehad M. Ayoub, Sathyen A. Prabhu, Matthew Gliksman, Betty Tai, Ahmet Hatipoglu, Andre Goy, and K. Stephen Suh
|
| 28693-28715 |
|
| Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials |
|
https://doi.org/10.18632/oncotarget.4747
Giuseppe Aprile, Caterina Fontanella, Marta Bonotto, Karim Rihawi, Stefania Eufemia Lutrino, Laura Ferrari, Mariaelena Casagrande, Elena Ongaro, Massimiliano Berretta, Antonio Avallone, Gerardo Rosati, Francesco Giuliani, and Gianpiero Fasola
|
| 28716-28730 |
|
| Vav1: A Dr Jekyll and Mr Hyde protein – good for the hematopoietic system bad for cancer |
|
https://doi.org/10.18632/oncotarget.5086
Shulamit Katzav
|
| 28731-28742 |
|
| Genetic interaction of P2X7 receptor and VEGFR2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients |
|
https://doi.org/10.18632/oncotarget.4926
Anna Solini, Vittorio Simeon, Lisa Derosa, Paola Orlandi, Chiara Rossi, Andrea Fontana, Luca Galli, Teresa Di Desidero, Anna Fioravanti, Sara Lucchesi, Luigi Coltelli, Laura Ginocchi, Giacomo Allegrini, Romano Danesi, Alfredo Falcone, and Guido Bocci
|
| 28743-28754 |
|
| Triplelayer dissection of the lung adenocarcinoma transcriptome – regulation at the gene transcript and exon levels |
|
https://doi.org/10.18632/oncotarget.4810
Min-Kung Hsu, I-Ching Wu, Ching-Chia Cheng, Jen-Liang Su, Chang-Huain Hsieh, Yeong-Shin Lin, and Feng-Chi Chen
|
| 28755-28773 |
|
| New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK |
|
https://doi.org/10.18632/oncotarget.4342
Daniela Di Paolo, D. Yang, Fabio Pastorino, Laura Emionite, Michele Cilli, Antonio Daga, Elisa Destefanis, Annarita Di Fiore, Francesca Piaggio, Chiara Brignole, Xiaobao Xu, Chris Liang, James Gibbons, Mirco Ponzoni, and Patrizia Perri
|
| 28774-28789 |
|
| The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1No correlation coefficient between VEGF and PROK1 |
|
https://doi.org/10.18632/oncotarget.4744
Takanori Goi, Toshiyuki Nakazawa, Yasuo Hirono, and Akio Yamaguchi
|
| 28790-28799 |
|
| Primary tumor and metastasisderived colon cancer cells differently modulate connexin expression and function in human capillary endothelial cells |
|
https://doi.org/10.18632/oncotarget.4894
Dominique Thuringer, Kevin Berthenet, Laurent Cronier, Eric Solary, and Carmen Garrido
|
| 28800-28815 |
|
| FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase3 dependent degradation |
|
https://doi.org/10.18632/oncotarget.5006
David W. Clark, Kaushlendra Tripathi, Josephine C. Dorsman, and Komaraiah Palle
|
| 28816-28832 |
|
| TAK1 and IKK2 novel mediators of SCFinduced signaling and potential targets for cKitdriven diseases |
|
https://doi.org/10.18632/oncotarget.5008
Sebastian Drube, Franziska Weber, Christiane Göpfert, Romy Loschinski, Mandy Rothe, Franziska Boelke, Michaela A. Diamanti, Tobias Löhn, Julia Ruth, Dagmar Schütz, Norman Häfner, Florian R. Greten, Ralf Stumm, Karin Hartmann, Oliver H. Krämer, Anne Dudeck, and Thomas Kamradt
|
| 28833-28850 |
|
| Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone Ainduced apoptosis of human cervical cancer cells |
|
https://doi.org/10.18632/oncotarget.4767
Jen-Pi Tsai, Chien-Hsing Lee, Tsung-Ho Ying, Chu-Liang Lin, Chia-Liang Lin, Jung-Tsung Hsueh, and Yi-Hsien Hsieh
|
| 28851-28866 |
|
| MiR21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway |
|
https://doi.org/10.18632/oncotarget.4814
Changjun He, Xuesong Dong, Bo Zhai, Xian Jiang, Deli Dong, Baoxin Li, Hongchi Jiang, Shidong Xu, and Xueying Sun
|
| 28867-28881 |
|
| MiR1207 overexpression promotes cancer stem cell–like traits in ovarian cancer by activating the Wnt/βcatenin signaling pathway |
|
https://doi.org/10.18632/oncotarget.4921
Geyan Wu, Aibin Liu, Jinrong Zhu, Fangyong Lei, Shu Wu, Xin Zhang, Liping Ye, Lixue Cao, and Shanyang He
|
| 28882-28894 |
|
| PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1 |
|
https://doi.org/10.18632/oncotarget.5000
Chiara Giorgi, Aleksandar Boro, Florian Rechfeld, Laura A. Lopez-Garcia, Maria E. Gierisch, Beat W. Schäfer, and Felix K. Niggli
|
| 28895-28910 |
|
| Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor |
|
https://doi.org/10.18632/oncotarget.5029
Keith Schutsky, De-Gang Song, Rachel Lynn, Jenessa B. Smith, Mathilde Poussin, Mariangela Figini, Yangbing Zhao, and Daniel J. Powell Jr.
|
| 28911-28928 |
|
| Identification and characterization of RET fusions in advanced colorectal cancer |
|
https://doi.org/10.18632/oncotarget.4325
Anne-France Le Rolle, Samuel J. Klempner, Christopher R. Garrett, Tara Seery, Eric M. Sanford, Sohail Balasubramanian, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, and Vi K. Chiu
|
| 28929-28937 |
|
| Inhibition of 13cis retinoic acidinduced gene expression of reactiveresistance genes by thalidomide in glioblastoma tumours in vivo |
|
https://doi.org/10.18632/oncotarget.4727
Dusan Milanovic, Carsten Sticht, Manuel Röhrich, Patrick Maier, Anca-L Grosu, and Carsten Herskind
|
| 28938-28948 |
|
| Loss of miR200b promotes invasion via activating the Kindlin2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An Ecadherinindependent mechanism |
|
https://doi.org/10.18632/oncotarget.5027
Hai-Feng Zhang, Abdulraheem Alshareef, Chengsheng Wu, Shang Li, Ji-Wei Jiao, Hui-Hui Cao, Raymond Lai, Li-Yan Xu, and En-Min Li
|
| 28949-28960 |
|
| Stat5deficient hematopoiesis is permissive for Mycinduced Bcell leukemogenesis |
|
https://doi.org/10.18632/oncotarget.5009
Zhengqi Wang, Magdalena Medrzycki, Silvia T. Bunting, and Kevin D. Bunting
|
| 28961-28972 |
|
| Metformin represses cancer cells via alternate pathways in Ncadherin expressing vs Ncadherin deficient cells |
|
https://doi.org/10.18632/oncotarget.5023
Rongbin Ge, Zongwei Wang, Shulin Wu, Yangjia Zhuo, Aleksandar G. Otsetov, Chao Cai, Weide Zhong, Chin-Lee Wu, and Aria F. Olumi
|
| 28973-28987 |
|
| Changes in the gene expression of cocultured human fibroblast cells and osteosarcoma cells: the role of microenvironment |
|
https://doi.org/10.18632/oncotarget.4902
Viviana Salvatore, Stefano Focaroli, Gabrielli Teti, Antonio Mazzotti, and Mirella Falconi
|
| 28988-28998 |
|
| A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme |
|
https://doi.org/10.18632/oncotarget.4905
Gilli Galore-Haskel, Yael Nemlich, Eyal Greenberg, Shira Ashkenazi, Motti Hakim, Orit Itzhaki, Noa Shoshani, Ronnie Shapira-Fromer, Eytan Ben-Ami, Efrat Ofek, Liat Anafi, Michal J. Besser, Jacob Schachter, and Gal Markel
|
| 28999-29015 |
|
| Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients |
|
https://doi.org/10.18632/oncotarget.5032
Miguel Angel Pavón, Irene Arroyo-Solera, Marta Téllez-Gabriel, Xavier León, David Virós, Montserrat López, Alberto Gallardo, Maria Virtudes Céspedes, Isolda Casanova, Antonio López-Pousa, Maria Antonia Mangues, Miquel Quer, Agustà Barnadas, and Ramón Mangues
|
| 29016-29033 |
|
| IL1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production |
|
https://doi.org/10.18632/oncotarget.4732
Pauline Escobar, Céline Bouclier, Julien Serret, Ivan Bièche, Madly Brigitte, Andres Caicedo, Elodie Sanchez, Sophie Vacher, Marie-Luce Vignais, Philippe Bourin, David Geneviève, Franck Molina, Christian Jorgensen, and Gwendal Lazennec
|
| 29034-29047 |
|
| HBV preS2 promotes the expression of TAZ via miRNA3383p to enhance the tumorigenesis of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.4804
Peng Liu, Hualin Zhang, Xiaohong Liang, Hongxin Ma, Fang Luan, Bo Wang, Fuxiang Bai, Lifen Gao, and Chunhong Ma
|
| 29048-29059 |
|
| TRIPBr1 oncoprotein inhibits autophagy apoptosis and necroptosis under nutrient/serumdeprived condition |
|
https://doi.org/10.18632/oncotarget.5072
Samil Jung, Chengping Li, Jingjing Duan, Soonduck Lee, Kyeri Kim, Yeonji Park, Young Yang, Keun-Il Kim, Jong-Seok Lim, Chung-Il Cheon, Young-Sook Kang, and Myeong-Sok Lee
|
| 29060-29075 |
|
| PDK1 induces JunB EMT cell migration and invasion in human gallbladder cancer |
|
https://doi.org/10.18632/oncotarget.4931
Shixian Lian, Yebo Shao, Houbao Liu, Junyi He, Weiqi Lu, Yong Zhang, Ying Jiang, and Jun Zhu
|
| 29076-29086 |
|
| Chromosomal catastrophe is a frequent event in clinically insignificant prostate cancer |
|
https://doi.org/10.18632/oncotarget.4900
Irina V. Kovtun, Stephen J. Murphy, Sarah H. Johnson, John C. Cheville, and George Vasmatzis
|
| 29087-29096 |
|
| Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.4829
Jochen K. Lennerz, Karl Hoffmann, Anna-Maria Bubolz, Davor Lessel, Claudia Welke, Nele Rüther, Andreas Viardot, and Peter Möller
|
| 29097-29110 |
|
| The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma |
|
https://doi.org/10.18632/oncotarget.5059
Tamás Barbai, Zsuzsanna FejÅ‘s, Laszlo G. Puskas, József TÃmár, and Erzsébet Rásó
|
| 29111-29128 |
|
| miR146b5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas |
|
https://doi.org/10.18632/oncotarget.4895
Jing Liu, Jinling Xu, Huining Li, Cuiyun Sun, Lin Yu, Yanyan Li, Cuijuan Shi, Xuexia Zhou, Xiuwu Bian, Yifang Ping, Yanjun Wen, Shujun Zhao, Hui Xu, Linlin Ren, Tongling An, Qian Wang, and Shizhu Yu
|
| 29129-29142 |
|
| Global phosphotyrosine survey in triplenegative breast cancer reveals activation of multiple tyrosine kinase signaling pathways |
|
https://doi.org/10.18632/oncotarget.5020
Xinyan Wu, Muhammad Saddiq Zahari, Binyun Ma, Ren Liu, Santosh Renuse, Nandini A. Sahasrabuddhe, Lily Chen, Raghothama Chaerkady, Min-Sik Kim, Jun Zhong, Christine Jelinek, Mustafa A. Bharbuiya, Pamela Leal-Rojas, Yi Yang, Manoj Kumar Kashyap, Arivusudar Marimuthu, Min Ling, Mary Jo Fackler, Vanessa Merino, Zhen Zhang, Cynthia A. Zahnow, Edward Gabrielson, Vered Stearns, Juan Carlos Roa, Saraswati Sukumar, Parkash S. Gill, and Akhilesh Pandey
|
| 29143-29160 |
|
| Chitosan nanoparticlemediated delivery of miRNA34a decreases prostate tumor growth in the bone and its expression induces noncanonical autophagy |
|
https://doi.org/10.18632/oncotarget.4971
Sanchaika Gaur, Yunfei Wen, Jian H. Song, Nila U. Parikh, Lingegowda S. Mangala, Alicia M. Blessing, Cristina Ivan, Sherry Y. Wu, Andreas Varkaris, Yan Shi, Gabriel Lopez-Berestein, Daniel E. Frigo, Anil K. Sood, and Gary E. Gallick
|
| 29161-29177 |
|
| Colorectal cancerpromoting activity of the senescent peritoneal mesothelium |
|
https://doi.org/10.18632/oncotarget.4932
Justyna Mikuła-Pietrasik, Patrycja Sosińska, Konstantin Maksin, Małgorzata Kucińska, Hanna Piotrowska, Marek Murias, Aldona Woźniak, Dariusz Szpurek, and Krzysztof Książek
|
| 29178-29195 |
|
| Upregulation of human cervical cancer protooncogene contributes to hepatitis B virusinduced malignant transformation of hepatocyte by downregulating Ecadherin |
|
https://doi.org/10.18632/oncotarget.5039
Junfeng Li, Xiaopeng Dai, Hongfei Zhang, Wei Zhang, Shihui Sun, Tongtong Gao, Zhihua Kou, Hong Yu, Yan Guo, Lanying Du, Shibo Jiang, Jianying Zhang, and Yusen Zhou
|
| 29196-29208 |
|
| H19 non coding RNAderived miR675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating cCbl and Cblb |
|
https://doi.org/10.18632/oncotarget.4976
Constance Vennin, Nathalie Spruyt, Fatima Dahmani, Sylvain Julien, François Bertucci, Pascal Finetti, Thierry Chassat, Roland P. Bourette, Xuefen Le Bourhis, and Eric Adriaenssens
|
| 29209-29223 |
|
| miR155 identified as antimetastatic by global miRNA profiling of a metastasis model inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations |
|
https://doi.org/10.18632/oncotarget.4942
Karina G. Thomsen, Mikkel G. Terp, Rikke R. Lund, Rolf Søkilde, Daniel Elias, Martin Bak, Thomas Litman, Hans C. Beck, Maria B. Lyng, and Henrik J. Ditzel
|
| 29224-29239 |
|
| TEL2 suppresses metastasis by downregulating SERPINE1 in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.5074
Yi Sang, Ming-yuan Chen, Donghua Luo, Ru-Hua Zhang, Li Wang, Mei Li, Rongzhen Luo, Chao-Nan Qian, Jian-Yong Shao, Yi-Xin Zeng, and Tiebang Kang
|
| 29240-29253 |
|
| The metastatic infiltration at the metastasis/brain parenchymainterface is very heterogeneous and has a significant impact on survival in a prospective study |
|
https://doi.org/10.18632/oncotarget.4201
Laila Siam, Annalen Bleckmann, Han-Ning Chaung, Alexander Mohr, Florian Klemm, Alonso Barrantes-Freer, Raquel Blazquez, Hendrik A. Wolff, Florian Lüke, Veit Rohde, Christine Stadelmann, and Tobias Pukrop
|
| 29254-29267 |
|
| Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis |
|
https://doi.org/10.18632/oncotarget.4922
Chung-Ji Liu, Wan-Jung Chang, Chang-Yi Chen, Fang-Ju Sun, Hui-Wen Cheng, Tsai-Ying Chen, Shu-Chun Lin, and Wan-Chun Li
|
| 29268-29284 |
|
| A fivemiRNA signature with prognostic and predictive value for MGMT promotermethylated glioblastoma patients |
|
https://doi.org/10.18632/oncotarget.4978
Wen Cheng, Xiufang Ren, Jinquan Cai, Chuanbao Zhang, Mingyang Li, Kuanyu Wang, Yang Liu, Sheng Han, and Anhua Wu
|
| 29285-29295 |
|
| High throughput screening of cytokines chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery |
|
https://doi.org/10.18632/oncotarget.4828
Dan Wang, Kebang Hu, Ningning Gao, Hao Zhang, Yanlin Jiang, Caigang Liu, Shouyu Wang, and Zuowei Zhao
|
| 29296-29310 |
|
| Effect of latent membrane protein 1 expression on overall survival in EpsteinBarr virusassociated cancers: a literaturebased metaanalysis |
|
https://doi.org/10.18632/oncotarget.4906
Yu-Pei Chen, Wen-Na Zhang, Lei Chen, Ling-Long Tang, Yan-Ping Mao, Wen-Fei Li, Xu Liu, Guan-Qun Zhou, Ying Sun, Tie-Bang Kang, Mu-Sheng Zeng, Na Liu, and Jun Ma
|
| 29311-29323 |
|
| Identification and characterization of ANO9 in stage II and III colorectal carcinoma |
|
https://doi.org/10.18632/oncotarget.4979
Chunxiang Li, Sanjun Cai, Xishan Wang, and Zheng Jiang
|
| 29324-29334 |
|
| Inactivation of M2 AChR/NFκB signaling axis reverses epithelialmesenchymal transition EMT and suppresses migration and invasion in nonsmall cell lung cancer NSCLC |
|
https://doi.org/10.18632/oncotarget.5004
Qingnan Zhao, Jinnan Yue, Chun Zhang, Xiajing Gu, Hongzhuan Chen, and Lu Xu
|
| 29335-29346 |
|
| A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation |
|
https://doi.org/10.18632/oncotarget.5119
Artem Artemov, Alexander Aliper, Michael Korzinkin, Ksenia Lezhnina, Leslie Jellen, Nikolay Zhukov, Sergey Roumiantsev, Nurshat Gaifullin, Alex Zhavoronkov, Nicolas Borisov, and Anton Buzdin
|
| 29347-29356 |
|
| Positive feedback loop of hepatomaderived growth factor and βcatenin promotes carcinogenesis of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.4982
Jiayan Lian, Jianming Tang, Huijuan Shi, Hui Li, Tiantian Zhen, Wenlin Xie, Fenfen Zhang, Yang Yang, and Anjia Han
|
| 29357-29374 |
|
| Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma |
|
https://doi.org/10.18632/oncotarget.4910
Raquel G. Coelho, Isadora C. Calaça, Deborah M. Celestrini, Ana Helena P. Correia-Carneiro, Mauricio M. Costa, Patricia Zancan, and Mauro Sola-Penna
|
| 29375-29387 |
|
| 18Ffluorodeoxyglucose FDG PET/CT after two cycles of neoadjuvant therapy may predict response in HER2negative but not in HER2positive breast cancer |
|
https://doi.org/10.18632/oncotarget.5001
Jingyi Cheng, Yujie Wang, Miao Mo, Xiao Bao, Yingjian Zhang, Guangyu Liu, Jun Zhang, and Daoying Geng
|
| 29388-29395 |
|
| Critical role of phosphorylation of serine 165 of YBX1 on the activation of NFκB in colon cancer |
|
https://doi.org/10.18632/oncotarget.5120
Lakshmi Prabhu, Rasika Mundade, Benlian Wang, Han Wei, Antja-Voy Hartley, Matthew Martin, Kyle McElyea, Constance J. Temm, George Sandusky, Yunlong Liu, and Tao Lu
|
| 29396-29412 |
|
| The PTTG1targeting miRNAs miR329 miR300 miR381 and miR655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop |
|
https://doi.org/10.18632/oncotarget.5003
Hai-qian Liang, Ren-jie Wang, Cai-feng Diao, Jian-wei Li, Jing-liang Su, and Sai Zhang
|
| 29413-29427 |
|
| Exposure to airborne PM25 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells |
|
https://doi.org/10.18632/oncotarget.5005
Chunling Liu, Huan Guo, Xinxin Cheng, Mingming Shao, Chen Wu, Suhan Wang, Hongmin Li, Lixuan Wei, Yanning Gao, Wen Tan, Shujun Cheng, Tangchun Wu, Dianke Yu, and Dongxin Lin
|
| 29428-29439 |
|
| TRAILmediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cellactivated natural killer cells |
|
https://doi.org/10.18632/oncotarget.4984
Martin Lelaidier, Yildian Dìaz-Rodriguez, Martine Cordeau, Paulo Cordeiro, Elie Haddad, Sabine Herblot, and Michel Duval
|
| 29440-29455 |
|
| Inhibition of DNArepair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a preclinical study |
|
https://doi.org/10.18632/oncotarget.4909
Sandra G. Boccard, Sandie V. Marand, Sandra Geraci, Laurie Pycroft, François R. Berger, and Laurent A. Pelletier
|
| 29456-29468 |
|
| Characterization of the metastatic phenotype of a panel of established osteosarcoma cells |
|
https://doi.org/10.18632/oncotarget.5177
Ling Ren, Arnulfo Mendoza, Jack Zhu, Joseph W. Briggs, Charles Halsey, Ellen S. Hong, Sandra S. Burkett, James J. Morrow, Michael M. Lizardo, Tanasa Osborne, Samuel Q. Li, Hue H. Luu, Paul Meltzer, and Chand Khanna
|
| 29469-29481 |
|
| Inhibition of autophagy potentiates pemetrexed and simvastatininduced apoptotic cell death in malignant mesothelioma and nonsmall cell lung cancer cells |
|
https://doi.org/10.18632/oncotarget.5022
Ki-Eun Hwang, Young-Suk Kim, Jae-Wan Jung, Su-Jin Kwon, Do-Sim Park, Byong-Ki Cha, Seon-Hee Oh, Kwon-Ha Yoon, Eun-Taik Jeong, and Hak-Ryul Kim
|
| 29482-29496 |
|
| Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1AMPK dependent Rho A activatio |
|
https://doi.org/10.18632/oncotarget.4985
Yurong Wang, Bin Wang, Mounia Guerram, Li Sun, Wei Shi, Chongchong Tian, Xiong Zhu, Zhenzhou Jiang, and Luyong Zhang
|
| 29497-29512 |
|
| Dietary prevention of Helicobacter pyloriassociated gastric cancer with kimchi |
|
https://doi.org/10.18632/oncotarget.4897
Migyeong Jeong, Jong-Min Park, Young-Min Han, Kun Young Park, Don Haeng Lee, Joon-Hwan Yoo, Joo Young Cho, and Ki-Baik Hahm
|
| 29513-29526 |
|
| MiR497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG1 |
|
https://doi.org/10.18632/oncotarget.5012
Jing-Jun Yan, Yu-Nan Zhang, Jia-Zhi Liao, Kun-peng Ke, Ying Chang, Pei-Yuan Li, Min Wang, Ju-Sheng Lin, and Xing-Xing He
|
| 29527-29542 |
|
| Capsaicin triggers immunogenic PEL cell death stimulates DCs and reverts PELinduced immune suppression |
|
https://doi.org/10.18632/oncotarget.4911
Marisa Granato, Maria Saveria Gilardini Montani, Maria Rosaria Filardi, Alberto Faggioni, and Mara Cirone
|
| 29543-29554 |
|
| Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential noninvasive biomarker for the detection of urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.4986
Chia-Ming Yeh, Pi-Che Chen, Hsiao-Yen Hsieh, Yeong-Chin Jou, Chang-Te Lin, Ming-Hsuan Tsai, Wen-Yu Huang, Yi-Ting Wang, Ru-Inn Lin, Szu-Shan Ch, Chun-Liang Tung, Shu-Fen Wu, De-Ching Chang, Cheng-Huang Shen, Cheng-Da Hsu, and Michael W.Y. Chan
|
| 29555-29572 |
|
| Stathmin 1 inhibition amplifies ruxolitinibinduced apoptosis in JAK2V617F cells |
|
https://doi.org/10.18632/oncotarget.4998
João Agostinho Machado-Neto, Paula de Melo Campos, Patricia Favaro, Mariana Lazarini, Adriana da Silva Santos Duarte, Irene Lorand-Metze, Fernando Ferreira Costa, Sara Teresinha Olalla Saad, and Fabiola Traina
|
| 29573-29584 |
|
| S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer |
|
https://doi.org/10.18632/oncotarget.4987
Ya-Ling Hsu, Jen-Yu Hung, Yung-Yu Liang, Yi-Shiuan Lin, Ming-Ju Tsai, Shah-Hwa Chou, Chi-Yu Lu, and Po-Lin Kuo
|
| 29585-29598 |
|
| A conserved RAD6MDM2 ubiquitin ligase machinery targets histone chaperone ASF1A in tumorigenesis |
|
https://doi.org/10.18632/oncotarget.5011
Chen Wang, Jian-Feng Chang, Hongli Yan, Da-Liang Wang, Yan Liu, Yuanya Jing, Meng Zhang, Yu-Long Men, Dongdong Lu, Xiao-Mei Yang, Su Chen, and Fang-Lin Sun
|
| 29599-29613 |
|
| RPS3 regulates melanoma cell growth and apoptosis by targeting Cyto C/Ca2+/MICU1 dependent mitochondrial signaling |
|
https://doi.org/10.18632/oncotarget.4868
Yun Tian, Lijun Qin, Huijuan Qiu, Dingbo Shi, Rui Sun, Wenbing Li, Tianze Liu, Jingshu Wang, Tingting Xu, Wei Guo, Tiebang Kang, Wenlin Huang, Guowen Wang, and Wuguo Deng
|
| 29614-29625 |
|
| CAVEOLIN1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance irrespective of tumor histotype |
|
https://doi.org/10.18632/oncotarget.4988
Eleonora Duregon, Rebecca Senetta, Alessandra Pittaro, Ludovica Verdun di Cantogno, Giulia Stella, Pierpaolo De Blasi, Michele Zorzetto, Cristina Mantovani, Mauro Papotti, and Paola Cassoni
|
| 29626-29636 |
|
| Cyclooxygenase2 in tumorassociated macrophages promotes breast cancer cell survival by triggering a positivefeedback loop between macrophages and cancer cells |
|
https://doi.org/10.18632/oncotarget.4936
Hongzhong Li, Bing Yang, Jing Huang, Yong Lin, Tingxiu Xiang, Jingyuan Wan, Hongyuan Li, Salem Chouaib, and Guosheng Ren
|
| 29637-29650 |
|
| Regulation and functional significance of CDC42 alternative splicing in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.4865
Xiaolong He, Chengfu Yuan, and Jilai Yang
|
| 29651-29663 |
|
| Antiangiogenic efficacy of 5′triphosphate siRNA combining VEGF silencing and RIGI activation in NSCLCs |
|
https://doi.org/10.18632/oncotarget.4869
Dongmei Yuan, Mao Xia, Gang Meng, Chun Xu, Yong Song, and Jiwu Wei
|
| 29664-29674 |
|
| CD151α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion |
|
https://doi.org/10.18632/oncotarget.4896
Pengcheng Zhou, Sonia Erfani, Zeyi Liu, Changhe Jia, Yecang Chen, Bingwei Xu, Xinyu Deng, Jose E. Alfáro, Li Chen, Dana Napier, Michael Lu, Jian-An Huang, Chunming Liu, Olivier Thibault, Rosalind Segal, Binhua P. Zhou, Natasha Kyprianou, Craig Horbinski, and Xiuwei H. Yang
|
| 29675-29693 |
|
| Differential targeting of the cyclindependent kinase inhibitor p21CIP1/WAF1 by chelators with antiproliferative activity in a range of tumor celltypes |
|
https://doi.org/10.18632/oncotarget.5088
Rayan S. Moussa, Zaklina Kovacevic, and Des R. Richardson
|
| 29694-29711 |
|
| Heat shock factor 1 an inhibitor of nonhomologous end joining repair |
|
https://doi.org/10.18632/oncotarget.5073
Ga-Young Kang, Eun-Ho Kim, Hae-June Lee, Na-Yeon Gil, Hyuk-Jin Cha, and Yun-Sil Lee
|
| 29712-29724 |
|
| CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74dependent manner |
|
https://doi.org/10.18632/oncotarget.5065
Richard D.A. Wilkinson, Sinead M. Magorrian, Rich Williams, Andrew Young, Donna M. Small, Christopher J. Scott, and Roberta E. Burden
|
| 29725-29739 |
|
| The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma |
|
https://doi.org/10.18632/oncotarget.4965
Heike Döppler, Ligia Bastea, Sahra Borges, Xochiquetzal Geiger, and Peter Storz
|
| 29740-29752 |
|
| The expression pattern of PFKFB3 enzyme distinguishes between inducedpluripotent stem cells and cancer stem cells |
|
https://doi.org/10.18632/oncotarget.4995
Artur Cieślar-Pobuda, Mayur Vilas Jain, Gunnar Kratz, Joanna Rzeszowska-Wolny, Saeid Ghavami, and Emilia Wiechec
|
| 29753-29770 |
|
| Disulfiram anticancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate |
|
https://doi.org/10.18632/oncotarget.4833
Ali Calderon-Aparicio, Mary Strasberg-Rieber, and Manuel Rieber
|
| 29771-29781 |
|
| FOXA1 regulates androgen receptor variant activity in models of castrateresistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.4927
Dominic Jones, Mark Wade, Sirintra Nakjang, Lewis Chaytor, James Grey, Craig N. Robson, and Luke Gaughan
|
| 29782-29794 |
|
| Aberrant reduction of telomere repetitive sequences in plasma cellfree DNA for early breast cancer detection |
|
https://doi.org/10.18632/oncotarget.5083
Xi Wu, and Hiromi Tanaka
|
| 29795-29807 |
|
| Double autophagy modulators reduce 2deoxyglucose uptake in sarcoma patients |
|
https://doi.org/10.18632/oncotarget.5060
Mau-Shin Chi, Cheng-Yen Lee, Su-Chen Huang, Kai-Lin Yang, Hui-Ling Ko, Yen-Kung Chen, Chen-Han Chung, Kuang-Wen Liao, and Kwan-Hwa Chi
|
| 29808-29817 |
|
| Agerelated obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans |
|
https://doi.org/10.18632/oncotarget.4904
Mehran Rahimi, Manlio Vinciguerra, Mojtaba Daghigh, Behiye Özcan, Vishtaseb Akbarkhanzadeh, Fareeba Sheedfar, Marzyeh Amini, Tommaso Mazza, Valerio Pazienza, Mahdi. M. Motazacker, Morteza Mahmoudi, Felix W.M. De Rooij, Eric Sijbrands, Maikel P. Peppelenbosch, and Farhad Rezaee
|
| 29818-29832 |
|
| Simvastatin and downstream inhibitors circumvent constitutive and stromal cellinduced resistance to doxorubicin in IGHV unmutated CLL cells |
|
https://doi.org/10.18632/oncotarget.4006
Micol Rigoni, Chiara Riganti, Candida Vitale, Valentina Griggio, Ivana Campia, Marta Robino, Myriam Foglietta, Barbara Castella, Patrizia Sciancalepore, Ilaria Buondonno, Daniela Drandi, Marco Ladetto, Mario Boccadoro, Massimo Massaia, and Marta Coscia
|
| 29833-29846 |
|
| NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK3β and Nur77 to prevent βcatenin degradation |
|
https://doi.org/10.18632/oncotarget.4913
Wen-Jing Lu, Mei-Sze Chua, Wei Wei, and Samuel K. So
|
| 29847-29859 |
|
| ELK1 is upregulated by androgen in bladder cancer cells and promotes tumor progression |
|
https://doi.org/10.18632/oncotarget.5007
Takashi Kawahara, Hasanain Khaleel Shareef, Ali Kadhim Aljarah, Hiroki Ide, Yi Li, Eiji Kashiwagi, George J. Netto, Yichun Zheng, and Hiroshi Miyamoto
|
| 29860-29876 |
|
| Pancreatic cancerderived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR2123p |
|
https://doi.org/10.18632/oncotarget.4924
Guoping Ding, Liangjing Zhou, Yingming Qian, Mingnian Fu, Jian Chen, Jionghuang Chen, Jianyang Xiang, Zhengrong Wu, Guixing Jiang, and Liping Cao
|
| 29877-29888 |
|
| Pretreatment with VEGFRinhibitors reduces interstitial fluid pressure increases intraperitoneal chemotherapy drug penetration and impedes tumor growth in a mouse colorectal carcinomatosis model |
|
https://doi.org/10.18632/oncotarget.5092
Félix Gremonprez, Benedicte Descamps, Andrei Izmer, Christian Vanhove, Frank Vanhaecke, Olivier De Wever, and Wim Ceelen
|
| 29889-29900 |
|
| NZ51 a ringexpanded nucleoside analog inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3 |
|
https://doi.org/10.18632/oncotarget.4898
Min Xie, Farhad Vesuna, Mahendran Botlagunta, Guus Martinus Bol, Ashley Irving, Yehudit Bergman, Ramachandra S Hosmane, Yoshinori Kato, Paul T Winnard Jr., and Venu Raman
|
| 29901-29913 |
|
| Alltrans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype |
|
https://doi.org/10.18632/oncotarget.4939
Camilla Pellegrini, Marta Columbaro, Cristina Capanni, Maria Rosaria D’Apice, Carola Cavallo, Michela Murdocca, Giovanna Lattanzi, and Stefano Squarzoni
|
| 29914-29928 |
|
| Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics |
|
https://doi.org/10.18632/oncotarget.4966
Jie Qiao, Cai-Yun Fang, Sun-Xia Chen, Xiao-Qing Wang, Shu-Jian Cui, Xiao-Hui Liu, Ying-Hua Jiang, Jie Wang, Yang Zhang, Peng-Yuan Yang, and Feng Liu
|
| 29929-29946 |
|
| Honokiol activates LKB1miR34a axis and antagonizes the oncogenic actions of leptin in breast cancer |
|
https://doi.org/10.18632/oncotarget.4937
Dimiter B. Avtanski, Arumugam Nagalingam, Michael Y. Bonner, Jack L. Arbiser, Neeraj K. Saxena, and Dipali Sharma
|
| 29947-29962 |
|
| Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ and HSF1dependent |
|
https://doi.org/10.18632/oncotarget.4676
Carole Sourbier, Bradley T. Scroggins, Philip Z. Mannes, Pei-Jyun Liao, Karsten Siems, Dietmar Wolf, John A. Beutler, W. Marston Linehan, and Leonard Neckers
|
| 29963-29974 |
|
| Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors |
|
https://doi.org/10.18632/oncotarget.5034
Seiko Kamimae, Eiichiro Yamamoto, Masahiro Kai, Takeshi Niinuma, Hiro-o Yamano, Masanori Nojima, Kennjiro Yoshikawa, Tomoaki Kimura, Ryo Takagi, Eiji Harada, Taku Harada, Reo Maruyama, Yasushi Sasaki, Takashi Tokino, Yasuhisa Shinomura, Tamotsu Sugai, Kohzoh Imai, and Hiromu Suzuki
|
| 29975-29990 |
|
| Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymalepithelial transition in nonsmallcell lung carcinoma |
|
https://doi.org/10.18632/oncotarget.5031
Kian Ngiap Chua, Li Ren Kong, Wen Jing Sim, Hsien Chun Ng, Weijie Richard Ong, Jean Paul Thiery, Hung Huynh, and Boon Cher Goh
|
| 29991-30005 |
|
| miR146b5p mediates p16dependent repression of IL6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts |
|
https://doi.org/10.18632/oncotarget.4933
Mysoon M. Al-Ansari, and Abdelilah Aboussekhra
|
| 30006-30016 |
|
| BaxPGAM5LDrp1 complex is required for intrinsic apoptosis execution |
|
https://doi.org/10.18632/oncotarget.5013
Wenjuan Xu, Linlin Jing, Quanshi Wang, Chung-Chih Lin, Xiaoting Chen, Jianxin Diao, Yuanliang Liu, and Xuegang Sun
|
| 30017-30034 |
|
| Automated tracking of tumorstroma morphology in microtissues identifies functional targets within the tumor microenvironment for therapeutic intervention |
|
https://doi.org/10.18632/oncotarget.5046
Malin Åkerfelt, Neslihan Bayramoglu, Sean Robinson, Mervi Toriseva, Hannu-Pekka Schukov, Ville Härmä, Johannes Virtanen, Raija Sormunen, Mika Kaakinen, Juho Kannala, Lauri Eklund, Janne Heikkilä, and Matthias Nees
|
| 30035-30056 |
|
| Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling |
|
https://doi.org/10.18632/oncotarget.4996
Juan Carlos Montero, Sara GarcÃa-Alonso, Alberto Ocaña, and Atanasio Pandiella
|
| 30057-30071 |
|
| Base excision repairmediated resistance to cisplatin in KRASG12C mutant NSCLC cells |
|
https://doi.org/10.18632/oncotarget.5019
Elisa Caiola, Daniela Salles, Roberta Frapolli, Monica Lupi, Giuseppe Rotella, Anna Ronchi, Marina Chiara Garassino, Nikola Mattschas, Stefano Colavecchio, Massimo Broggini, Lisa Wiesmüller, and Mirko Marabese
|
| 30072-30087 |
|
| The HGF inhibitory peptide HGP1 displays promising in vitro and in vivo efficacy for targeted cancer therapy |
|
https://doi.org/10.18632/oncotarget.3937
Lisha Chen, Chunlin Li, and Yimin Zhu
|
| 30088-30101 |
|
| Inhibition of glucose6phosphate dehydrogenase sensitizes cisplatinresistant cells to death |
|
https://doi.org/10.18632/oncotarget.4945
Daniela Catanzaro, Edoardo Gaude, Genny Orso, Carla Giordano, Giulia Guzzo, Andrea Rasola, Eugenio Ragazzi, Laura Caparrotta, Christian Frezza, and Monica Montopoli
|
| 30102-30114 |
|
| Dissecting the contribution of EBNA3C domains important for EBVinduced Bcell growth and proliferation |
|
https://doi.org/10.18632/oncotarget.5002
Hem Chandra Jha, Sanket Kumar Shukla, Jie Lu, Mahadesh Prasad Aj, Shuvomoy Banerjee, and Erle S. Robertson
|
| 30115-30129 |
|
| Vacciniarelated kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition |
|
https://doi.org/10.18632/oncotarget.4967
Namgyu Lee, Jung-Hee Kwon, Young Bae Kim, Seong-Hoon Kim, Sung Jin Park, Weiguang Xu, Hoe-Yune Jung, Kyong-Tai Kim, Hee Jung Wang, and Kwan Yong Choi
|
| 30130-30148 |
|
| Targeting autophagy enhances the antitumoral action of crizotinib in ALKpositive anaplastic large cell lymphoma |
|
https://doi.org/10.18632/oncotarget.4999
Géraldine Mitou, Julie Frentzel, Aurore Desquesnes, Sophie Le Gonidec, Talal AlSaati, Isabelle Beau, Laurence Lamant, Fabienne Meggetto, Estelle Espinos, Patrice Codogno, Pierre Brousset, and Sylvie Giuriato
|
| 30149-30164 |
|
| RASSF8 regulates progression of cutaneous melanoma through nuclear factorκb |
|
https://doi.org/10.18632/oncotarget.5030
Jinhua Wang, Wei Hua, Sharon K. Huang, Kun Fan, Ling Takeshima, Ying Mao, and Dave S.B. Hoon
|
| 30165-30177 |
|
| Functional chemical genomic and superenhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma |
|
https://doi.org/10.18632/oncotarget.4903
Alyssa L. Kennedy, Mounica Vallurupalli, Liying Chen, Brian Crompton, Glenn Cowley, Francisca Vazquez, Barbara A. Weir, Aviad Tsherniak, Sudha Parasuraman, Sunkyu Kim, Gabriela Alexe, and Kimberly Stegmaier
|
| 30178-30193 |
|
| Membrane associated canceroocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors |
|
https://doi.org/10.18632/oncotarget.4734
Eusebio S Pires, Ryan S D’Souza, Marisa A Needham, Austin K Herr, Amir A Jazaeri, Hui Li, Mark H Stoler, Kiley L Anderson-Knapp, Theodore Thomas, Arabinda Mandal, Alain Gougeon, Charles J Flickinger, David E Bruns, Brian A Pollok, and John C Herr
|
| 30194-30211 |
|
| Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors |
|
https://doi.org/10.18632/oncotarget.4901
Daniela Damiani, Mario Tiribelli, Donatella Raspadori, Santina Sirianni, Alessia Meneghel, Margherita Cavalllin, Angela Michelutti, Eleonora Toffoletti, Antonella Geromin, Erica Simeone, Monica Bocchia, and Renato Fanin
|
| 30212-30221 |
|
| Histidinerich glycoprotein function in hepatocellular carcinoma depends on its Nglycosylation status and it regulates cell proliferation by inhibiting Erk1/2 phosphorylation |
|
https://doi.org/10.18632/oncotarget.4997
Qinle Zhang, Kai Jiang, Yan Li, Dongmei Gao, Lu Sun, Shu Zhang, Tianhua Liu, Kun Guo, and Yinkun Liu
|
| 30222-30231 |
|
| IDH1/2 mutation status combined with Ki67 labeling index defines distinct prognostic groups in glioma |
|
https://doi.org/10.18632/oncotarget.4920
Ailiang Zeng, Qi Hu, Yanwei Liu, Zheng Wang, Xiaoming Cui, Rui Li, Wei Yan, and Yongping You
|
| 30232-30238 |
|
| MiRNA10a is upregulated in NSCLC and may promote cancer by targeting PTEN |
|
https://doi.org/10.18632/oncotarget.4972
Tao Yu, Lei Liu, Jing Li, Mingxia Yan, Hechun Lin, Ying Liu, Dandan Chu, Hong Tu, Aiqin Gu, and Ming Yao
|
| 30239-30250 |
|
| LDL suppresses angiogenesis through disruption of the HIF pathway via NFκB inhibition which is reversed by the proteasome inhibitor BSc2118 |
|
https://doi.org/10.18632/oncotarget.4943
Gang Yao, Qi Zhang, Thorsten R. Doeppner, Feng Niu, Qiaochuan Li, Yanping Yang, Ulrike Kuckelkorn, Nina Hagemann, Wei Li, D.M. Hemann, Wen Zhou, and Fengyan Jin
|
| 30251-30262 |
|
| Nuclear HDAC6 inhibits invasion by suppressing NFκB/MMP2 and is inversely correlated with metastasis of nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.4749
Chih-Jen Yang, Yu-Peng Liu, Hong-Ying Dai, Yow-Ling Shiue, Chia-Jung Tsai, Ming-Shyan Huang, and Yao-Tsung Yeh
|
| 30263-30276 |
|
| Extramural depth of rectal cancer tumor invasion at thinsection MRI: predicting treatment response to neoadjuvant chemoradiation |
|
https://doi.org/10.18632/oncotarget.4623
Tong Tong, Yiqun Sun, Sanjun Cai, Zhen Zhang, and Yajia Gu
|
| 30277-30286 |
|
| Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV nonsmall cell lung cancer treated with platinum doublet chemotherapy |
|
https://doi.org/10.18632/oncotarget.4711
Anna K. Brady, Jonathan D. McNeill, Brendan Judy, Joshua Bauml, Tracey L. Evans, Roger B. Cohen, Corey Langer, Anil Vachani, and Charu Aggarwal
|
| 30287-30294 |
|
| IDH mutation 1p19q codeletion and ATRX loss in WHO grade II gliomas |
|
https://doi.org/10.18632/oncotarget.4497
Heather E. Leeper, Alissa A. Caron, Paul A. Decker, Robert B. Jenkins, Daniel H. Lachance, and Caterina Giannini
|
| 30295-30305 |
|
| Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Finher phase III randomized trial |
|
https://doi.org/10.18632/oncotarget.5080
Amir Sonnenblick, Sylvain Brohée, Debora Fumagalli, Françoise Rothé, Delphine Vincent, Michael Ignatiadis, Christine Desmedt, Roberto Salgado, Nicolas Sirtaine, Sherene Loi, Patrick Neven, Sibylle Loibl, Carsten Denkert, Heikki Joensuu, Martine Piccart, and Christos Sotiriou
|
| 30306-30316 |
|
| Posttreatment plasma EBVDNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase |
|
https://doi.org/10.18632/oncotarget.4505
Liang Wang, Hua Wang, Jing-hua Wang, Zhong-jun Xia, Yue Lu, Hui-qiang Huang, Wen-qi Jiang, and Yu-jing Zhang
|
| 30317-30326 |
|
| Expression of high affinity folate receptor in breast cancer brain metastasis |
|
https://doi.org/10.18632/oncotarget.4639
José Pablo Leone, Rohit Bhargava, Brian K. Theisen, Ronald L. Hamilton, Adrian V. Lee, and Adam M. Brufsky
|
| 30327-30333 |
|
| Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy cART in HIV+ patients with advanced Kaposi sarcoma |
|
https://doi.org/10.18632/oncotarget.4571
Rosamaria Tedeschi, Ettore Bidoli, Maria Teresa Bortolin, Ornella Schioppa, Emanuela Vaccher, and Paolo De Paoli
|
| 30334-30342 |
|
| High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer |
|
https://doi.org/10.18632/oncotarget.4850
Jose Luis Lopez-Guerra, Eva M. Verdugo-Sivianes, Daniel Otero-Albiol, Begoña Vieites, Maria J. Ortiz-Gordillo, Jose M. De León, Juan M. Praena-Fernandez, Juan J. Marin, and Amancio Carnero
|
| 30343-30356 |
|
| Identification of prostate cancer biomarkers in urinary exosomes |
|
https://doi.org/10.18632/oncotarget.4851
Anders Øverbye, Tore Skotland, Christian J. Koehler, Bernd Thiede, Therese Seierstad, Viktor Berge, Kirsten Sandvig, and Alicia Llorente
|
| 30357-30376 |
|
| Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older |
|
https://doi.org/10.18632/oncotarget.4599
Jue-feng Wan, Ji Zhu, Gui-chao Li, Wen-jie Sun, and Zhen Zhang
|
| 30377-30383 |
|
| 89Zrcetuximab PET imaging in patients with advanced colorectal cancer |
|
https://doi.org/10.18632/oncotarget.4672
Catherina Willemien Menke-van der Houven, Elske C Gootjes, Marc C Huisman, Danielle J Vugts, Chantal Roth, Anne Marije Luik, Emma R Mulder, Robert C Schuit, Ronald Boellaard, Otto S Hoekstra, Guus AMS van Dongen, and Henk MW Verheul
|
| 30384-30393 |
|
| Critical role of bevacizumab scheduling in combination with presurgical chemoradiotherapy in MRIdefined highrisk locally advanced rectal cancer: Results of the BRANCH trial |
|
https://doi.org/10.18632/oncotarget.4724
Antonio Avallone, Biagio Pecori, Franco Bianco, Luigi Aloj, Fabiana Tatangelo, Carmela Romano, Vincenza Granata, Pietro Marone, Alessandra Leone, Gerardo Botti, Antonella Petrillo, Corradina Caracò, Vincenzo R. Iaffaioli, Paolo Muto, Giovanni Romano, Pasquale Comella, Alfredo Budillon, and Paolo Delrio
|
| 30394-30407 |
|
| A phase 2 openlabel multicenter study of the longterm safety of siltuximab an antiinterleukin6 monoclonal antibody in patients with multicentric Castleman disease |
|
https://doi.org/10.18632/oncotarget.4655
Frits van Rhee, Corey Casper, Peter M. Voorhees, Luis E. Fayad, Helgi van de Velde, Jessica Vermeulen, Xiang Qin, Ming Qi, Brenda Tromp, and Razelle Kurzrock
|
| 30408-30419 |
|
| Retraction: Guggulsterone inhibits prostate cancer growth via inactivation of Akt regulated by ATP citrate lyase signaling |
|
https://doi.org/10.18632/oncotarget.6005
Yajuan Gao, Yan Zeng, Jian Tian, Mohammad Shyful Islam, Guoqin Jiang, and Dong Xiao
|
| 30420 |
